The Recall Desk

Manufacturer

Brandywine Pharmaceuticals, LLC

2 recalls in our database name Brandywine Pharmaceuticals, LLC as the manufacturing or recalling firm.

What the numbers show

Total
2
Critical
0
Severe
0
Most recent
2026-11-04

Of the 2 recalls from Brandywine Pharmaceuticals, LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–2 of 2

  • ModerateFDA (Drugs)·D-0110-2027·2026-11-04

    Brandywine Recalls Theophylline Extended-Release Tablets Due to Stability Testing Interruption

    Brandywine Pharmaceuticals is recalling 1,620 bottles of Theophylline Extended-Release Tablets, 100 mg, due to an interruption in stability testing.

    Product
    Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0111-2027·2026-11-04

    Brandywine Recalls Theophylline Extended-Release Tablets Due to Stability Testing Interruption

    Brandywine Pharmaceuticals is recalling 1,332 bottles of Theophylline Extended-Release Tablets because an interruption in stability testing at a third-party laboratory created a potential quality concern.

    Product
    Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.
    Category
    Drug
    Distribution
    Distributed nationwide